期刊文献+

瑞舒伐他汀钙治疗老年冠心病合并高脂血症的疗效分析 被引量:33

瑞舒伐他汀钙治疗老年冠心病合并高脂血症的疗效分析
下载PDF
导出
摘要 目的探讨使用瑞舒伐他汀钙治疗老年冠心病合并高脂血症的疗效。方法将我院2010年10月~2011年10月冠心病合并高脂血症的患者94例随机分为2组,对照组患者47例给予阿托伐他汀钙治疗,实验组患者给予瑞舒伐他汀钙治疗,比较2组患者治疗2个月后的疗效。结果经统计学分析,实验组患者血清总胆固醇、甘油三酯及低密度脂蛋白低于对照组患者,P〈0.05,差异有统计学意义;实验组患者高密度脂蛋白高于对照组患者,P〈0.05。结论使用瑞舒伐他汀钙治疗老年冠心病合并高脂血症具有较好的效果,可以提高疗效、降低血脂,具有较高的临床意义。 Objective To investigate the efficacy of statins calcium treatment of elderly coronary heart disease and hyperlipidemia Ruishu cutting. Methods Hospital in October 2010 to October 2011, 94 cases of patients with coronary heart disease and hyper- lipidemia were randomly divided into two groups, control group of 47 patients given atorvastatin calcium treatment, the experimen- tal group were treated with Ruishu atorvastatin calcium therapy, two groups were compared 2 months post-treatment efficacy. Re- suits After statistical analysis, the experimental group, serum total cholesterol, triglycerides and LDL lower than control group pa- tients, P〈0.05, the difference was statistically significant; higher than the control patients of experimental group patients with high- density lipoprotein, P〈0.05. Conclusion The use of rosuvastatin calcium treatment of elderly coronary heart disease merger hyper- lipidemia with good results, can improve efficacy, reduce blood fat, with a high clinical significance.
出处 《中国卫生产业》 2012年第14期23-23,25,共2页 China Health Industry
关键词 瑞舒伐他汀钙 冠心病 高脂血症 治疗效果 Ruishu cutting statins calcium Coronary heart disease Hyperlipidemia Treatment
  • 相关文献

参考文献5

二级参考文献34

共引文献172

同被引文献154

  • 1陈懿,徐世鄂.瑞舒伐他汀和阿托伐他汀对冠心病患者的调脂作用和安全性比较[J].中国老年学杂志,2014,34(9):2389-2390. 被引量:93
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5228
  • 3胡大一 马长生.心脏病学实践[M].北京:人民卫生出版社,2004.625-626.
  • 4刘乐.80例老年冠心病合并高脂血症患者予瑞舒伐他汀钙治疗疗效观察[J].健康大视野,2012,20(11):367.
  • 5Zhou Q, Liao JK. Pleiotropie effects of statina-Basic research and clinical perspectives [ J ]. Circ J, 2010,74 ( 5 ) : 818-$26.
  • 6Stephen J, Nicholls M B, et al. Effect of two intensive statin Regi- mens on progression of coronary disease [ J ~. AM J N Engl J Med 2011,365 ( 8 ) :2078-2087.
  • 7TAKAGI H, UMEMOTO T. A meta-analysis of randomized head-to- head trials for effects of rosuvastatin versus atorvastatin on apolipopro- tein profiles [J]. Am J Cardiol,2014,113 (2):292-301.
  • 8Patel,H.,Rathod,R.,Dash,R.P. et al.Simuhaneous quantification of rosu- vastatin and fenofibric acid by HPLC-UV in rat plasma and its applica- tion to pharmacokinetic study [J].Journal of liquid chromatography and related technologies,2014,37(9/12): 1673-1684.
  • 9Semenova AE,Sergienko IV,Masenko VP,et al. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients[J]. Acta Cardiol,2009,64(3):405 -9.
  • 10Ballantyne CM,Bertolami M,Hernandez GHR,et al. Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapy (MERCURY) II[J]. Am Heart J,2006,151 (5):975.

引证文献33

二级引证文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部